1)Wald DS, et al:Combination therapy versus monotherapy in reducing blood pressure:meta-analysis on 11,000 participants from 42 trials. Am J Med 122:290-300, 2009
2)Mancia G, et al:Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines:specific indications rather than ranking for general usage. J Hypertens 26:164-168, 2008
3)Lindholm LH, Carlberg B, Samuelsson O:Should b blockers remain first choice in the treatment of hypertension? Lancet 366:1545-1553, 2005
4)Law MR, Morris JK, Wald NJ:Use of blood pressure lowering drugs in the prevention of cardiovascular disease:meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338:1665-1683, 2009
5)Blood Pressure Lowering Treatment Trialists' Collaboration:Effects of different regimen to lower blood pressure on major cardiovascular events in older and younger adults. BMJ 336:1121-1123(electric resource:doi:10.1136/bmj. 39548.738368. BE), 2008
6)Balamuthusamy S, et al:Comparative analysis of beta-blockers with other antihypertensive agents on cardiovascular outcomes in hypertensive patients with diabetes mellitus:a systemic review and meta-analysis. Am J Ther 16:133-142, 2009
7)The CAFE Investigators, for the Anglo-Scandinavian Cardiac Outcomes Trial Investigators:Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation(CAFE)Study. Circulation 113:1213-1225, 2006
8)Bangalore S, et al:Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol 52:1482-1489, 2008
9)Mancia G, et al:Reappraisal of European guidelines on hypertension:a European Society of Hypertension Task Force document. J Hypertens 27:2121-2158, 2009
10)築山久一郎:高血圧治療におけるβ遮断薬の再評価.Ther Res 31:431-453, 2010